JINHAI MED TECH (02225.HK) enters strategic cooperation MOU with DHC on business operations and equity investment
NewTimeSpace News: On 3 November 2026, Jinhai Medical Technology Limited (02225.HK) announced voluntarily that on 2 November it entered into a strategic cooperation memorandum of understanding with Digital Health China Technologies Co., Ltd. ("DHC") regarding potential cooperation in business operations and equity investment.
Under the MOU, the parties intend to leverage their respective comparative advantages in resources, technology, marketing and management to build a mutually beneficial relationship, exploring potential business project acquisitions at the operations level and equity investment opportunities. The specific cooperation terms, implementation approach, project timetable and the respective rights and obligations of the parties will be subject to a formal agreement to be negotiated, so the proposed transactions under the MOU may or may not proceed.
From the date of the MOU to 31 March 2027, the company has the exclusive right to negotiate and complete the proposed matters with DHC. DHC is a joint stock company established in China, principally engaged in the medical big data and artificial intelligence business in the healthcare industry, and is an independent third party.
- HK Stock Connect Insight | JINHAI MED TECH (02225.HK): Minimally invasive surgery revenue rises to 74.7% of total; southbound stake rises to 0.90% after Stock Connect entry on Sept 7
- Jinhai Med Tech (02225.HK): Appoints Ma Chengdong as Chief Marketing Officer to Accelerate Foray into Neurosurgical Endoscopy Sector
- JINHAI MED TECH (02225.HK): Appoints Li Bin as Executive Director and Co-Chairman
